Selective Retina Therapy with Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients

Table 2

Treatment outcomes for 16 included patients.

Case number	Best-corrected visual acuity			Central foveal thickness (μm)			Subretinal fluid			Clinical course after 3 months
	Baseline	1 M	3 M	Baseline	1 M	3 M	Baseline	1 M	3 M
1	20/60	20/60	20/50	507	314	197	+	+	−	No recurrence of fluid for 7 M confirmed by clinical examination
2	20/30	20/25	20/20	483	267	223	+	+	−	No recurrence of fluid for 6 M confirmed by OCT
3	20/50	20/40	20/30	657	388	252	+	+	−	No recurrence of fluid for 6 M confirmed by clinical examination
4	20/25	20/20	20/20	528	241	223	+	+	−
5	20/25	20/20	20/20	488	228	226	+	−	−	No recurrence of fluid for 5 M confirmed by clinical examination
6	20/50	20/40	20/40	621	223	226	+	−	−	No recurrence of fluid for 5 M by OCT
7	20/40	20/25	20/20	316	222	228	+	−	−	No recurrence of fluid for 6 M by OCT
8	20/25	20/20	20/20	320	212	216	+	−	−
9	20/20	20/20	20/20	499	229	223	+	−	−
10	20/30	20/25	20/25	584	234	231	+	−	−	No recurrence of fluid for 6 M by OCT
11	20/25	20/20	20/20	444	213	206	+	−	−
12	20/60	20/50	20/50	284	188	187	+	−	−	No recurrence of fluid for 5 M by OCT
13	20/50	20/40	20/40	290	211	204	+	+	−
14	20/30	20/30	20/30	341	220	223	+	−	−
15	20/30	20/25	20/25	422	203	201	+	−	−
16	20/40	20/30	20/30	278	191	183	+	−	−

M: month; +: present; −: absent; OCT: optical coherence tomography.